• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Sex differences in vaccine-induced immunity in mice immunized with integrase-defective lentiviral vector delivering the SARS-CoV-2

tetano

Editor, Senior Moderator
Front Immunol


. 2026 Mar 4:17:1778067.
doi: 10.3389/fimmu.2026.1778067. eCollection 2026.
Sex differences in vaccine-induced immunity in mice immunized with integrase-defective lentiviral vector delivering the SARS-CoV-2 Spike protein

Iole Farina[SUP] #[/SUP][SUP] 1 [/SUP], Alessandra Gallinaro[SUP] #[/SUP][SUP] 2 [/SUP], Martina Borghi[SUP] 1 [/SUP], Maria Franca Pirillo[SUP] 2 [/SUP], Chiara Falce[SUP] 2 [/SUP], Andrea Canitano[SUP] 2 [/SUP], Zuleika Michelini[SUP] 2 [/SUP], Alice Zappitelli[SUP] 1 [/SUP], Antonio Di Virgilio[SUP] 3 [/SUP], Mario Picozza[SUP] 4 [/SUP], Andrea Cara[SUP] 2 [/SUP], Donatella Negri[SUP] 1 [/SUP]


Affiliations
Abstract

Introduction: Integrase-defective lentiviral vector (IDLV) delivering the optimized SARS-CoV-2 Spike protein induces strong and persistent immunity in mice. Here, we investigate potential sex-dependent differences by comparing female and male mice for germinal center (GC) reactions and Spike-specific immune responses induced by IDLV delivering an optimized SARS-CoV-2 Spike Wuhan-Hu-1 protein (IDLV-S).
Methods: Female and male BALB/c mice were injected once intramuscularly with either IDLV-S or IDLV-Mock or were left untreated. Blood, lymph nodes and spleens were collected at selected time points for the analysis of immune responses by flow cytometry, FluoroSpot and neutralization assays.
Results: Strong GC activation was detected at 7 days from the immunization in all vaccinated mice, showing a higher percentage of GC B cells in females. Anti-Spike neutralizing antibodies (nAbs) and T cell responses were detected up to 24 weeks from immunization in all IDLV-S immunized mice. NAbs in sera were more persistent in female than in male mice, and vaccinated females also showed a higher cross-neutralization activity against Spikes from variants of concern, reflecting a better quality of the functional immune response. Both IDLV-S immunized groups showed specific T cell responses evaluated as IFNγ/TNFα producing T cells, with a higher response in females.
Discussion: The higher GC reaction in the immunized females can be the trigger for the more persistent and broader nAb response in females compared to males. Our data confirm sex-dependent vaccine-induced immune responses and support the need of appropriate design of vaccine protocols both at the preclinical and clinical levels.

Keywords: Spike; T cell response; germinal center; integrase-defective lentiviral vector; neutralizing antibody; preclinical study; sex differences; vaccine.

 
Back
Top Bottom